Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats

Abe, 1999, Detection of melatonin, its precursors and related enzyme activities in rabbit lens, Exp Eye Res, 68, 255, 10.1006/exer.1998.0601

Abramov, 2005, The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides, Philos Trans R Soc Lond B Biol Sci, 360, 2309, 10.1098/rstb.2005.1766

Alkam, 2007, A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25-35), Behav Brain Res, 180, 139, 10.1016/j.bbr.2007.03.001

Bland, 2007, Septohippocampal properties of N-methyl-D-aspartate-induced theta-band oscillation and synchrony, Synapse, 61, 185, 10.1002/syn.20357

Bland, 2001, Theta band oscillation and synchrony in the hippocampal formation and associated structures: The case for its role in sensorimotor integration, Behav Brain Res, 127, 119, 10.1016/S0166-4328(01)00358-8

Bliss, 1993, A synaptic model of memory: Long-term potentiation in the hippocampus, Nature, 361, 31, 10.1038/361031a0

Butterfield, 2005, The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity, Biochim Biophys Acta, 1703, 149, 10.1016/j.bbapap.2004.10.014

Chen, 2000, Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides, J Neurosci Res, 60, 65, 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q

Chen, 2012, Alterations in NADPH oxidase expression and blood-brain barrier in bile duct ligation-treated young rats: Effects of melatonin, Neurochem Int, 60, 751, 10.1016/j.neuint.2012.03.021

Cheng, 2004, The induction of amyloid precursor protein and alpha-synuclein in rat hippocampal astrocytes by diethyldithiocarbamate and copper with or without glutathione, Toxicol Lett, 146, 139, 10.1016/j.toxlet.2003.09.009

Cheung, 2003, The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion, J Pineal Res, 34, 153, 10.1034/j.1600-079X.2003.00034.x

Cheung, 2006, Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration, J Pineal Res, 41, 337, 10.1111/j.1600-079X.2006.00372.x

Clementi, 2006, Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: An intriguing role for methionine 35, Biochem Biophys Res Commun, 342, 206, 10.1016/j.bbrc.2006.01.137

Colell, 2009, Mitochondria, cholesterol and amyloid beta peptide: A dangerous trio in Alzheimer disease, J Bioenerg Biomembr, 41, 417, 10.1007/s10863-009-9242-6

Collins, 1997, Melatonin blocks the induction of long-term potentiation in an N-methyl-D-aspartate independent manner, Brain Res, 767, 162, 10.1016/S0006-8993(97)00733-6

Cooke, 2006, Plasticity in the human central nervous system, Brain, 129, 1659, 10.1093/brain/awl082

Crouch, 2006, Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide, J Neurochem, 99, 226, 10.1111/j.1471-4159.2006.04050.x

Ding, 2012, Beta-amyloid (1-40) peptide interactions with supported phospholipid membranes: A single-molecule study, Biophys J, 103, 1500, 10.1016/j.bpj.2012.08.051

Dragicevic, 2011, Melatonin treatment restores mitochondrial function in Alzheimer's mice: A mitochondrial protective role of melatonin membrane receptor signaling, J Pineal Res, 51, 75, 10.1111/j.1600-079X.2011.00864.x

Ersahin, 2009, Melatonin reduces experimental subarachnoid hemorrhage-induced oxidative brain damage and neurological symptoms, J Pineal Res, 46, 324, 10.1111/j.1600-079X.2009.00664.x

Feng, 2006, Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease, Free Radic Biol Med, 40, 101, 10.1016/j.freeradbiomed.2005.08.014

Ferreira, 2007, Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases, IUBMB Life, 59, 332, 10.1080/15216540701283882

Frautschy, 2010, Why pleiotropic interventions are needed for Alzheimer's disease, Mol Neurobiol, 41, 392, 10.1007/s12035-010-8137-1

Freir, 2003, A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil, J Neurophysiol, 89, 3061, 10.1152/jn.00992.2002

Guo, 2010, [Gly(14)]-humanin rescues long-term potentiation from amyloid beta protein-induced impairment in the rat hippocampal CA1 region in vivo, Synapse, 64, 83, 10.1002/syn.20707

Ha, 2012, PI3K-ERK1/2 activation contributes to extracellular H2O2 generation in amyloid beta toxicity, Neurosci Lett, 526, 112, 10.1016/j.neulet.2012.08.023

Hamel, 2008, Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease, Exp Physiol, 93, 116, 10.1113/expphysiol.2007.038729

Han, 2013, Liraglutide protects against amyloid-beta protein-induced impairment of spatial learning and memory in rats, Neurobiol Aging, 34, 576, 10.1016/j.neurobiolaging.2012.04.009

Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994

Ionov, 2011, Mechanism of neuroprotection of melatonin against beta-amyloid neurotoxicity, Neuroscience, 180, 229, 10.1016/j.neuroscience.2011.02.045

Itkin, 2011, Calcium ions promote formation of amyloid beta-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease, PLoS One, 6, e18250, 10.1371/journal.pone.0018250

Jou, 2004, Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes, J Pineal Res, 37, 55, 10.1111/j.1600-079X.2004.00140.x

Kanski, 2002a, Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide, Free Radic Biol Med, 32, 1205, 10.1016/S0891-5849(02)00821-3

Kanski, 2002b, Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity, Biochim Biophys Acta, 1586, 190, 10.1016/S0925-4439(01)00097-7

Kwon, 2010, Melatonin potentiates the neuroprotective properties of resveratrol against beta-amyloid-induced neurodegeneration by modulating AMP-activated protein kinase pathways, J Clin Neurol, 6, 127, 10.3988/jcn.2010.6.3.127

Kwon, 2011, Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: A possible role in neuroprotection, J Pineal Res, 50, 110, 10.1111/j.1600-079X.2010.00820.x

Leszkowicz, 2007, Modulation of hippocampal theta rhythm by the opioid system of the pedunculopontine tegmental nucleus, Acta Neurobiol Exp (Wars, 67, 447, 10.55782/ane-2007-1661

Li, 2009, Abeta(31-35)-induced neuronal apoptosis is mediated by JNK-dependent extrinsic apoptosis pathway, Neurosci Bull, 25, 361, 10.1007/s12264-009-0629-5

Li, 2012, Dexamethasone and Abeta(2)(5)-(3)(5) accelerate learning and memory impairments due to elevate amyloid precursor protein expression and neuronal apoptosis in 12-month male rats, Behav Brain Res, 227, 142, 10.1016/j.bbr.2011.10.038

Lisman, 2010, Working memory: The importance of theta and gamma oscillations, Curr Biol, 20, R490, 10.1016/j.cub.2010.04.011

Liu, 1999, Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype, J Clin Endocrinol Metab, 84, 323, 10.1210/jc.84.1.323

Logothetis, 2003, The underpinnings of the BOLD functional magnetic resonance imaging signal, J Neurosci, 23, 3963, 10.1523/JNEUROSCI.23-10-03963.2003

Maat-Schieman, 2000, Age-related plaque morphology and C-terminal heterogeneity of amyloid beta in Dutch-type hereditary cerebral hemorrhage with amyloidosis, Acta Neuropathol, 99, 409, 10.1007/s004010051143

Mattson, 2004, Pathways towards and away from Alzheimer's disease, Nature, 430, 631, 10.1038/nature02621

Misiti, 2005, 3,5,3'-Triiodo-L-thyronine enhances the differentiation of a human pancreatic duct cell line (hPANC-1) towards a beta-cell-Like phenotype, J Cell Physiol, 204, 286, 10.1002/jcp.20293

Molter, 2012, Rhythmic modulation of theta oscillations supports encoding of spatial and behavioral information in the rat hippocampus, Neuron, 75, 889, 10.1016/j.neuron.2012.06.036

Olcese, 2009, Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease, J Pineal Res, 47, 82, 10.1111/j.1600-079X.2009.00692.x

Ozcan, 2006, Effects of melatonin on synaptic transmission and long-term potentiation in two areas of mouse hippocampus, Brain Res, 1111, 90, 10.1016/j.brainres.2006.06.117

Pan, 2011, Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice, J Neurosci, 31, 13420, 10.1523/JNEUROSCI.2075-11.2011

Pan, 2010, Arginine vasopressin prevents against Abeta(25-35)-induced impairment of spatial learning and memory in rats, Horm Behav, 57, 448, 10.1016/j.yhbeh.2010.01.015

Patil, 2006, Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons, Neurosci Lett, 406, 55, 10.1016/j.neulet.2006.07.015

Pieri, 1994, Melatonin: A peroxyl radical scavenger more effective than vitamin E, Life Sci, 55, PL271, 10.1016/0024-3205(94)00666-0

Pratico, 2008, Oxidative stress hypothesis in Alzheimer's disease: A reappraisal, Trends Pharmacol Sci, 29, 609, 10.1016/j.tips.2008.09.001

Pratico, 2000, Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: Correlation of a noninvasive index of lipid peroxidation with disease severity, Ann Neurol, 48, 809, 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9

Qi, 2001, Amyloid beta-protein fragment 31-35 forms ion channels in membrane patches excised from rat hippocampal neurons, Neuroscience, 105, 845, 10.1016/S0306-4522(01)00244-5

Sanchez, 2012, Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model, Proc Natl Acad Sci U S A, 109, E2895, 10.1073/pnas.1121081109

Schilling, 2011, Amyloid-beta-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia, J Cell Physiol, 226, 3295, 10.1002/jcp.22675

Serrano-Pozo, 2012, Stable size distribution of amyloid plaques over the course of Alzheimer disease, J Neuropathol Exp Neurol, 71, 694, 10.1097/NEN.0b013e31825e77de

Shaftel, 2008, The role of interleukin-1 in neuroinflammation and Alzheimer disease: An evolving perspective, J Neuroinflammation, 5, 7, 10.1186/1742-2094-5-7

Shen, 2007, Suppressive effects of melatonin on amyloid-beta-induced glial activation in rat hippocampus, Arch Med Res, 38, 284, 10.1016/j.arcmed.2006.10.007

Shen, 2002a, Protective effects of melatonin on cortico-hippocampal neurotoxicity induced by amyloid beta-peptide 25-35, Acta Pharmacol Sin, 23, 71

Shen, 2002b, Melatonin reduces memory changes and neural oxidative damage in mice treated with D-galactose, J Pineal Res, 32, 173, 10.1034/j.1600-079x.2002.1o850.x

Stewart, 1991, Hippocampal theta activity in monkeys, Brain Res, 538, 59, 10.1016/0006-8993(91)90376-7

Sultana, 2009, Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: Role of Abeta in pathogenesis, Acta Neuropathol, 118, 131, 10.1007/s00401-009-0517-0

Tamagno, 2008, Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein, J Neurochem, 104, 683, 10.1111/j.1471-4159.2007.05072.x

Tuppo, 2001, Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease, Brain Res Bull, 54, 565, 10.1016/S0361-9230(01)00450-6

Vanderwolf, 1969, Hippocampal electrical activity and voluntary movement in the rat, Electroencephalogr Clin Neurophysiol, 26, 407, 10.1016/0013-4694(69)90092-3

Varadarajan, 2000, Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity, J Struct Biol, 130, 184, 10.1006/jsbi.2000.4274

Varadarajan, 1999, Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress, Brain Res Bull, 50, 133, 10.1016/S0361-9230(99)00093-3

Verret, 2012, Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model, Cell, 149, 708, 10.1016/j.cell.2012.02.046

Vertes, 1997, Brainstem-diencephalo-septohippocampal systems controlling the theta rhythm of the hippocampus, Neuroscience, 81, 893

Vorhees, 2006, Morris water maze: Procedures for assessing spatial and related forms of learning and memory, Nat Protoc, 1, 848, 10.1038/nprot.2006.116

Wang, 2005, Melatonin inhibits hippocampal long-term potentiation, Eur J Neurosci, 22, 2231, 10.1111/j.1460-9568.2005.04408.x

Wiechmann, 2013, Role of melatonin and its receptors in the vertebrate retina, Int Rev Cell Mol Biol, 300, 211, 10.1016/B978-0-12-405210-9.00006-0

Wimo A Prince MJ International AsD 2010 World Alzheimer Report 2010: The global economic impact of dementia

Winson, 1978, Loss of hippocampal theta rhythm results in spatial memory deficit in the rat, Science, 201, 160, 10.1126/science.663646

Wu, 2008, Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo, Brain Res Bull, 77, 84, 10.1016/j.brainresbull.2008.06.005

Xia, 2001, Amyloid metabolism and secretases in Alzheimer's disease, Curr Neurol Neurosci Rep, 1, 422, 10.1007/s11910-001-0101-z

Xia, 2003, Amyloid inhibitors and Alzheimer's disease, Curr Opin Investig Drugs, 4, 55

Xiao, 2002, Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation, J Neurosci Res, 67, 30, 10.1002/jnr.10075

Yan, 1999, Beta-amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons, Neuroscience, 92, 177, 10.1016/S0306-4522(98)00727-1

Ye, 1999, Suppressive action produced by beta-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: It's offset by (-)huperzine A, Neurosci Lett, 275, 187, 10.1016/S0304-3940(99)00795-8

Yoder, 2005, Involvement of GABAergic and cholinergic medial septal neurons in hippocampal theta rhythm, Hippocampus, 15, 381, 10.1002/hipo.20062

Zhang, 2009, Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo, Neurobiol Learn Mem, 91, 226, 10.1016/j.nlm.2008.11.004

Zhang, 2006, Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo, Synapse, 60, 307, 10.1002/syn.20302

Zhou, 2003, Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels, J Pineal Res, 35, 125, 10.1034/j.1600-079X.2003.00065.x

Zucker, 2002, Short-term synaptic plasticity, Ann Rev Physiol, 64, 355, 10.1146/annurev.physiol.64.092501.114547